Organon To Report Third Quarter Results and Host Conference Call on November 2, 2023
19 Oktober 2023 - 1:30PM
Business Wire
Organon (NYSE: OGN), a global healthcare company with a focus on
women’s health, will release its third quarter 2023 financial
results on November 2, 2023, prior to the company’s webcast and
conference call scheduled for 8:30 a.m. EST. Interested parties may
access the live call via webcast on the Organon website at
https://www.organon.com/investor-relations/events-and-presentations/.
A replay of the webcast will be available approximately two hours
after the conclusion of the live event on the company’s
website.
Institutional investors and analysts interested in participating
in the call must register in advance by clicking on this link:
https://conferencingportals.com/event/VfCOQYEG.
Following registration, participants will receive a confirmation
email containing details on how to join the conference call,
including dial-in information and a unique passcode and registrant
ID. Pre-registration will allow participants to bypass an operator
and be placed directly into the call.
About Organon
Organon is a global healthcare company formed to focus on
improving the health of women throughout their lives. Organon
offers more than 60 medicines and products in women’s health in
addition to a growing biosimilars business and a large franchise of
established medicines across a range of therapeutic areas.
Organon’s existing products produce strong cash flows that support
investments in innovation and future growth opportunities in
women’s health and biosimilars. In addition, Organon is pursuing
opportunities to collaborate with biopharmaceutical innovators
looking to commercialize their products by leveraging its scale and
presence in fast growing international markets.
Organon has a global footprint with significant scale and
geographic reach, world-class commercial capabilities, and
approximately 10,000 employees with headquarters located in Jersey
City, New Jersey.
For more information, visit http://www.organon.com and connect
with us on LinkedIn, Instagram, Twitter and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231019256069/en/
Organon Media:
Karissa Peer (614) 314-8094 Kate Vossen (732) 675-8448
Organon Investor:
Jennifer Halchak (201) 275-2711 Alex Arzeno (203) 550-3972
Organon (NYSE:OGN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Organon (NYSE:OGN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024